Current Management of Ductal Carcinoma In Situ (DCIS)

Jun 4, 2017 by in ONCOLOGY Comments Off on Current Management of Ductal Carcinoma In Situ (DCIS)

Fig. 11.1 (a) Low-grade ductal carcinoma in situ (grade 1): low-grade monomorphic nuclei, inconspicuous nucleoli, diffuse chromatin, cells maintain polarity around gland-like spaces, no comedo necrosis. (b) Intermediate-grade ductal carcinoma…

read more

The Emerging Role of Prophylactic Mastectomy

Jun 4, 2017 by in ONCOLOGY Comments Off on The Emerging Role of Prophylactic Mastectomy

Patient  Young age  White race  Private insurance  Family history of breast cancer Tumor  Infiltrating lobular histology  Multicentric disease  Tumor size Treatment  BRCA testing  MRI  Breast reconstruction  Facility type Reasons for…

read more

Anabolics

May 31, 2017 by in ENDOCRINOLOGY Comments Off on Anabolics

Fig. 3.1 PTH causes accrual of new bone by mainly remodeling-based “overfilling” of resorption pits (lower panel), but a certain degree of modeling-based accrual of bone on surfaces without preceding…

read more

Management of Atypical Femoral Fractures

May 31, 2017 by in ENDOCRINOLOGY Comments Off on Management of Atypical Femoral Fractures

Fig. 11.1 Atypical femur fracture treated with intramedullary nail showing sclerotic margins consistent with nonunion Complete fractures are treated most commonly with intramedullary devices; more proximal fractures that are difficult…

read more

Antiresorptives

May 31, 2017 by in ENDOCRINOLOGY Comments Off on Antiresorptives

Fig. 2.1 Structures of major bisphosphonates used clinically Bisphosphonates have been used since the 1970s across the whole spectrum of bone resorption disorders , including Paget’s disease and cancer-related bone…

read more
Get Clinical Tree app for offline access